Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Calmodulin 2 pseudogene 4 (CALM2P4) is a nonfunctional genomic segment that closely resembles the Calmodulin 2 (CALM2) gene[5][8][14]. Pseudogenes like CALM2P4 do not encode active proteins, and typically lack direct biological function, therapeutic targeting relevance, or clear disease association as a drug target[11][14]. CALM2P4 belongs to the category of pseudogenes arising by duplication or other molecular events that disrupt functional potential while retaining sequence similarity to their parent gene[5][11][14]. The "CALM2P4" designation specifically identifies it as one of several calmodulin 2 pseudogenes found within the human genome, and it is not considered a receptor, enzyme, transporter, transcription factor, or other canonical therapeutic target[5][14]. There is no current evidence associating CALM2P4 with disease, drug interaction, or use as a biomarker in the literature or curated databases[5][11][14].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Calmodulin 2 pseudogene 4 (CALM2P4).